Founded by Dr. Nic Waddell and Prof. John Pearson of the QIMR Berghofer Medical Research Institute, genomiQa combines expertise in whole genome biology, analysis, and clinical reporting.

genomiQa collaborates with pharmaceutical and biotech companies to incorporate whole genome analysis into clinical development. They also work with health systems to integrate this advanced analysis for both cancer (CapeDx) and germline (GulfDx) applications. With a focus on bringing quality genomics to clinical settings, genomiQa is seeking venture investment to expand their international reach.

The genomiQa team comprises exceptional experts in the field. Dr. Nic Waddell has extensive experience in interpreting whole genome next-generation sequence data, while Prof.

John Pearson is a leading figure in genome informatics. They have both contributed to prestigious projects such as the 1000 Genomes Project and the International Cancer Genome Consortium. By making whole genome analysis the norm rather than the exception, genomiQa aims to revolutionize healthcare and empower personalized medicine.

Contact genomiQa for more information on their plans and services